Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells - Centre Paul Papin Accéder directement au contenu
Article Dans Une Revue Oncogenesis Année : 2020

Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells

Résumé

Cancer cells are characterized by the Warburg effect, a shift from mitochondrial respiration to oxidative glycolysis. We report here the crucial role of cyclin D1 in promoting this effect in a cyclin-dependent kinase (CDK)4/6-independent manner in multiple myeloma (MM) cells. We show that the cyclin D1 oncoprotein targets hexokinase 2 (HK2), a major glycolysis regulator, through two original molecular mechanisms in the cytoplasmic and nuclear compartments. In the cytoplasm, cyclin D1 binds HK2 at the outer mitochondrial membrane, and in the nucleus, it binds hypoxia-inducible factor-1α (HIF1α), which regulates HK2 gene transcription. We also show that high levels of HK2 expression are correlated with shorter event-free survival (EFS) and overall survival (OS) in MM patients. HK2 may therefore be considered as a possible target for antimyeloma therapy.

Domaines

Cancer
Fichier principal
Vignette du fichier
Caillot Oncogenesis 2020.pdf (3.4 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02908131 , version 1 (28-07-2020)

Identifiants

Citer

M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. Mazure, et al.. Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩. ⟨hal-02908131⟩
198 Consultations
127 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More